TR10 10mg*10vials

Tirzepatide TR10 10mg*10vials

Tirzepatide is a dual GLP-1 and GIP receptor agonist peptide, representing a next-generation metabolic research compound that activates two gut hormone pathways simultaneously.

The 10mg single-vial specification is the standard concentration, ideal for initial dual-pathway studies, dose-response experiments, and researchers conducting foundational GLP-1/GIP co-activation research. This concentration offers flexibility in experimental design, allowing researchers to explore various dose levels while studying the synergistic effects of dual receptor activation.

Through combined GLP-1 and GIP receptor activation, this compound supports research into insulin sensitivity, glycemic regulation, appetite-related signaling, and metabolic homeostasis. The dual pathway approach provides a broader scope for studying systemic metabolic regulation compared to single-receptor compounds.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Each batch undergoes rigorous purity testing, with a certificate of analysis provided.

10 vials per pack, suitable for foundational laboratory research and dual-pathway metabolic mechanism studies.